These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22264575)

  • 1. Benefits associated with achieving optimal risk factor levels for the primary prevention of cardiovascular disease in older men.
    Robinson JG; Rahilly-Tierney C; Lawler E; Gaziano JM
    J Clin Lipidol; 2012; 6(1):58-65. PubMed ID: 22264575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial.
    Fowkes FG; Price JF; Stewart MC; Butcher I; Leng GC; Pell AC; Sandercock PA; Fox KA; Lowe GD; Murray GD;
    JAMA; 2010 Mar; 303(9):841-8. PubMed ID: 20197530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
    Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
    JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.
    Schmucker C; Eisele-Metzger A; Meerpohl JJ; Lehane C; Kuellenberg de Gaudry D; Lohner S; Schwingshackl L
    Cochrane Database Syst Rev; 2022 Feb; 2(2):CD013556. PubMed ID: 35199850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial.
    Sesso HD; Christen WG; Bubes V; Smith JP; MacFadyen J; Schvartz M; Manson JE; Glynn RJ; Buring JE; Gaziano JM
    JAMA; 2012 Nov; 308(17):1751-60. PubMed ID: 23117775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
    N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periodontal disease and risk of subsequent cardiovascular disease in U.S. male physicians.
    Howell TH; Ridker PM; Ajani UA; Hennekens CH; Christen WG
    J Am Coll Cardiol; 2001 Feb; 37(2):445-50. PubMed ID: 11216961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials.
    Christen WG; Gaziano JM; Hennekens CH
    Ann Epidemiol; 2000 Feb; 10(2):125-34. PubMed ID: 10691066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial.
    Ridker PM; Manson JE; Gaziano JM; Buring JE; Hennekens CH
    Ann Intern Med; 1991 May; 114(10):835-9. PubMed ID: 2014943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Migraine and subsequent risk of stroke in the Physicians' Health Study.
    Buring JE; Hebert P; Romero J; Kittross A; Cook N; Manson J; Peto R; Hennekens C
    Arch Neurol; 1995 Feb; 52(2):129-34. PubMed ID: 7848119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-selected posttrial aspirin use and subsequent cardiovascular disease and mortality in the physicians' health study.
    Cook NR; Hebert PR; Manson JE; Buring JE; Hennekens CH
    Arch Intern Med; 2000 Apr; 160(7):921-8. PubMed ID: 10761956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study).
    Goicoechea M; de Vinuesa SG; Quiroga B; Verde E; Bernis C; Morales E; Fernández-Juárez G; de Sequera P; Verdalles U; Delgado R; Torres A; Arroyo D; Abad S; Ortiz A; Luño J
    Cardiovasc Drugs Ther; 2018 Jun; 32(3):255-263. PubMed ID: 29943364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
    Anand SS; Bosch J; Eikelboom JW; Connolly SJ; Diaz R; Widimsky P; Aboyans V; Alings M; Kakkar AK; Keltai K; Maggioni AP; Lewis BS; Störk S; Zhu J; Lopez-Jaramillo P; O'Donnell M; Commerford PJ; Vinereanu D; Pogosova N; Ryden L; Fox KAA; Bhatt DL; Misselwitz F; Varigos JD; Vanassche T; Avezum AA; Chen E; Branch K; Leong DP; Bangdiwala SI; Hart RG; Yusuf S;
    Lancet; 2018 Jan; 391(10117):219-229. PubMed ID: 29132880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease.
    Rees K; Takeda A; Martin N; Ellis L; Wijesekara D; Vepa A; Das A; Hartley L; Stranges S
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD009825. PubMed ID: 30864165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Final report on the aspirin component of the ongoing Physicians' Health Study.
    Steering Committee of the Physicians' Health Study Research Group
    N Engl J Med; 1989 Jul; 321(3):129-35. PubMed ID: 2664509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of aspirin use and primary prevention of cardiovascular disease in women.
    Manson JE; Stampfer MJ; Colditz GA; Willett WC; Rosner B; Speizer FE; Hennekens CH
    JAMA; 1991 Jul 24-31; 266(4):521-7. PubMed ID: 2061978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes.
    Elam MB; Ginsberg HN; Lovato LC; Corson M; Largay J; Leiter LA; Lopez C; O'Connor PJ; Sweeney ME; Weiss D; Friedewald WT; Buse JB; Gerstein HC; Probstfield J; Grimm R; Ismail-Beigi F; Goff DC; Fleg JL; Rosenberg Y; Byington RP;
    JAMA Cardiol; 2017 Apr; 2(4):370-380. PubMed ID: 28030716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin).
    Pagidipati NJ; Navar AM; Pieper KS; Green JB; Bethel MA; Armstrong PW; Josse RG; McGuire DK; Lokhnygina Y; Cornel JH; Halvorsen S; Strandberg TE; Delibasi T; Holman RR; Peterson ED;
    Circulation; 2017 Sep; 136(13):1193-1203. PubMed ID: 28626088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus.
    Berkelmans GFN; Gudbjörnsdottir S; Visseren FLJ; Wild SH; Franzen S; Chalmers J; Davis BR; Poulter NR; Spijkerman AM; Woodward M; Pressel SL; Gupta AK; van der Schouw YT; Svensson AM; van der Graaf Y; Read SH; Eliasson B; Dorresteijn JAN
    Eur Heart J; 2019 Sep; 40(34):2899-2906. PubMed ID: 30629157
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.